Related Experiment Video
Updated: Jun 3, 2025

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.2K
Infections Management in the Lung Transplant Setting in Italy: A Web-Survey.
Andrea Lombardi1,2, Paolo Grossi3, Malgorzata Mikulska4,5
1Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Infectious Diseases Unit, Milano, Italy.
Summary
Infection prevention and management in Italian lung transplant (LuTx) centers show significant variation. A survey revealed diverse practices in prophylaxis and screening, highlighting the need for standardized protocols in LuTx care.
Area of Science:
- Medical research
- Transplantation medicine
- Infectious disease management
Background:
- Infections pose a significant threat to lung transplant (LuTx) recipients, impacting morbidity and mortality.
- Current practices for infection prevention and management in Italian LuTx centers require documentation.
Purpose of the Study:
- To survey and document current practices for infection prevention and management in lung transplant (LuTx) recipients across Italy.
Main Methods:
- A 52-question online survey was distributed to all Italian LuTx centers from December 1, 2023, to January 31, 2024.
- The survey assessed center characteristics, team organization, microbiological investigations, and infection prevention/management strategies.
Main Results:
- Nine of ten centers participated, with most performing adult LuTx.
- Practices varied for cytomegalovirus (CMV) prophylaxis (67% use prophylaxis, variable duration), Human herpesvirus 8 (HHV-8) screening (45%), and antibiotic prophylaxis (67% use dual regimen, 72h or 7 days duration).
- Fungal infection prophylaxis was used by a minority (44%), with inhaled amphotericin B being common. Infectious diseases specialists are involved early in recipient management (89%).
Conclusions:
- Considerable heterogeneity exists in infection management strategies among Italian LuTx centers.
- Establishing a shared platform for data collection and outcome evaluation is crucial for improving infection management in LuTx recipients.

